BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19498298)

  • 1. Purulent pericarditis in a dog administered immune-suppressing drugs.
    Mohri T; Takashima K; Yamane T; Sato H; Yamane Y
    J Vet Med Sci; 2009 May; 71(5):669-72. PubMed ID: 19498298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive therapy for canine immune-mediated hemolytic anemia.
    Al-Ghazlat S
    Compend Contin Educ Vet; 2009 Jan; 31(1):33-41, 44; quiz 44. PubMed ID: 19241356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
    Elwood C; Polton G
    J Vet Intern Med; 2008; 22(5):1075. PubMed ID: 18844828
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of idiopathic immune-mediated hemolytic anemia with mycophenolate mofetil in five dogs.
    West LD; Hart JR
    J Vet Emerg Crit Care (San Antonio); 2014; 24(2):226-31. PubMed ID: 24251650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic candidiasis in a dog, developing spondylitis.
    Kuwamura M; Ide M; Yamate J; Shiraishi Y; Kotani T
    J Vet Med Sci; 2006 Oct; 68(10):1117-9. PubMed ID: 17085895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Three months of prednisolone is enough treatment for IHA].
    Haneveld JK
    Tijdschr Diergeneeskd; 2011 Sep; 136(9):654-5. PubMed ID: 21939018
    [No Abstract]   [Full Text] [Related]  

  • 7. Canine immune-mediated hemolytic anemia: pathophysiology, clinical signs, and diagnosis.
    Balch A; Mackin A
    Compend Contin Educ Vet; 2007 Apr; 29(4):217-25. PubMed ID: 17726851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study.
    Piek CJ; van Spil WE; Junius G; Dekker A
    BMC Vet Res; 2011 Apr; 7():15. PubMed ID: 21489250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of immunosuppressive regimens for immune-mediated haemolytic anaemia: a retrospective study of 42 dogs.
    Swann JW; Skelly BJ
    J Small Anim Pract; 2011 Jul; 52(7):353-8. PubMed ID: 21668886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-mediated hemolytic anemia: 70 cases (1988-1996).
    Reimer ME; Troy GC; Warnick LD
    J Am Anim Hosp Assoc; 1999; 35(5):384-91. PubMed ID: 10493413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A suspected case of a multiple autoimmune syndrome in a poodle dog.
    Lim D; Jin Y; Son Y; Oh T; Bae S
    Vet Med Sci; 2022 Mar; 8(2):431-436. PubMed ID: 35137556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002).
    Weinkle TK; Center SA; Randolph JF; Warner KL; Barr SC; Erb HN
    J Am Vet Med Assoc; 2005 Jun; 226(11):1869-80. PubMed ID: 15934255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Alternaria infectoria infection in a dog in association with therapeutic immunosuppression for the management of immune-mediated haemolytic anaemia.
    Dedola C; Stuart AP; Ridyard AE; Else RW; van den Broek AH; Choi JS; de Hoog GS; Thoday KL
    Vet Dermatol; 2010 Dec; 21(6):626-34. PubMed ID: 20500496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppressive therapy in dogs and cats. Properties of drugs and their use in various immune-mediated diseases].
    Rieder J; Mischke R
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2018 Apr; 46(2):105-118. PubMed ID: 29727898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of immune-mediated hemolytic anemia in dogs with cyclophosphamide.
    Burgess K; Moore A; Rand W; Cotter SM
    J Vet Intern Med; 2000; 14(4):456-62. PubMed ID: 10935898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated haemolytic anaemia: possible association with Ancylostoma caninum infection in three dogs.
    Lobetti RG; Schoeman T
    J S Afr Vet Assoc; 2001 Mar; 72(1):52-4. PubMed ID: 11563722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
    Piek CJ; Junius G; Dekker A; Schrauwen E; Slappendel RJ; Teske E
    J Vet Intern Med; 2008; 22(2):366-73. PubMed ID: 18346140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of enoxaparin in dogs with primary immune-mediated hemolytic anemia: 21 cases.
    Panek CM; Nakamura RK; Bianco D
    J Vet Emerg Crit Care (San Antonio); 2015; 25(2):273-7. PubMed ID: 25773906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially antigenic RBC membrane proteins in dogs with primary immune-mediated hemolytic anemia.
    Tan E; Bienzle D; Shewen P; Kruth S; Wood D
    Vet Clin Pathol; 2012 Mar; 41(1):45-55. PubMed ID: 22315967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenectomy as an adjunctive treatment for dogs with immune-mediated hemolytic anemia: ten cases (2003-2006).
    Horgan JE; Roberts BK; Schermerhorn T
    J Vet Emerg Crit Care (San Antonio); 2009 Jun; 19(3):254-61. PubMed ID: 19691510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.